![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 26, 2012 2:23:41 AM
The scientists did what hey promised they would do. Create transgenics that had spider protein expressed in the silk.
Kim has been activated since June 2011 once a commercial strain was created to do his part of the job, which is get a partner. Instead, he has insisted on focusing on lab updates to drive the company.
Once he realizes he is not a scientist, and not a sales person, nor an IR person this company may grow some legs. Once he finally outsources to more talented and capable people, things will start moving at a more normal pace, until then we are a minnow trying to buddy up with blue fin tuna.
He is a wanna be scientist, not a true business man. That is why on the KBLB website he is wearing a lab coat (not his by the way, nor is the microscope, nor any of the materials in that lab. Its all ND's stuff).
You want proof that they are operating out of their own lab now, wait until they have updated pictures on the website. Unfortunately, I can only imagine that Kim will be in the pictures acting like he is doing the research, which is factually untrue. There are very talented researchers that work their buts off, that deserve more than they get. If you want to play dress up great, if you want to get partners, something must change.
As a result based on past timelines we wont see anything substantial in a year, at which point many will have cut their losses. As each month passes with no partner, more debt is accumulated and the likelihood of partners is reduced.
The ducks were not in a row and everything is being done reactively rather than proactively.
Its a shame because this really had some potential because the science is real.
This is all merely my opinion
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM